{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-25-002817","form_type":"8-K","ticker":"BBNX","cik":"0001674632","company_name":"Beta Bionics, Inc.","filed_at":"2025-05-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.298378+00:00","generated_at":"2026-05-22T12:44:39.408571+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Beta Bionics Q1 revenue up 36% to $17.6M; net loss widens; raises 2025 guidance","bullets":["Net sales $17.6M (+36% YoY); DME $13.8M (+14%), PBP $3.8M (+360%).","Installed customer base 19,151 (+291%); 3,853 new patient starts (+48%).","Gross margin 50.9% (down 482 bps); operating loss $18.6M; net loss $28.7M.","Cash and investments $295.5M as of March 31, 2025.","Raised full-year 2025 annual guidance (specific numeric targets not in excerpt)."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-25-002817","json":"https://secwatch.observer/filing/0001171843-25-002817.json","markdown":"https://secwatch.observer/filing/0001171843-25-002817.md","text":"https://secwatch.observer/filing/0001171843-25-002817.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1674632/000117184325002817/0001171843-25-002817-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1674632/000117184325002817/f8k_050625.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T12:44:39.408571+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}